Unlock banal picks and a broker-level newsfeed that powers Wall Street.
Prosper Junior Bakiny, The Motley Fool
Fri, Mar 28, 2025, 7:15 AM 4 min read
In This Article:
Dividend investing is an fantabulous strategy for (at least) 2 reasons. Companies that tin supply accordant payouts mostly person robust underlying operations. Also, reinvesting the dividend tin importantly boost semipermanent returns.
However, dividend stocks aren't each adjacent -- it's indispensable to enactment your hard-earned wealth successful companies that are improbable to trim oregon slash their payouts anytime soon, preferably ever. Here are 2 companies that tin propulsion it off: Amgen (NASDAQ: AMGN) and Coca-Cola (NYSE: KO).
Amgen paid its archetypal dividend successful 2011. Since then, it has accrued its payouts consistently:
The biotech could support that up for a agelong time, fixed its fantabulous prospects. Amgen is simply a starring drugmaker with a lineup of medicines crossed galore therapeutic areas. In 2024, the institution had 13 products that each generated much than $1 cardinal successful sales.
True, immoderate of them are losing steam owed to competition, whether biosimilar oregon otherwise, but others are stepping up. In 2024, Amgen recorded $972 cardinal successful income (increasing 71% twelvemonth implicit year) from its asthma medicine, Tezspire, the rights to which it shares with AstraZeneca. This therapy precocious aced a signifier 3 survey for the attraction of chronic rhinosinusitis (inflamed sinuses), truthful expect a statement enlargement successful this indication. Several much of the company's medicines should gain plentifulness of caller indications.
Amgen is besides processing brand-new ones. Amgen's enactment successful the value absorption marketplace has been noteworthy of late. Though the company's starring campaigner successful this field, MariTide, didn't rather unrecorded up to marketplace expectations successful a signifier 2 objective trial, it's excessively aboriginal to springiness up connected this project. The institution is moving 2 signifier 3 studies for MariTide successful obesity and diabetes.
Amgen's enactment goes acold beyond MariTide; its late-stage pipeline unsocial features 33 programs. Thanks to its ample portfolio of investigational products, the institution looks acceptable to make newer medicines consistently and present beardown fiscal results, helping enactment its fantabulous dividend program. Amgen is highly improbable to suspend oregon adjacent chopped its payouts anytime soon, making it an fantabulous prime for income seekers.
Beverage behemoth Coca-Cola has accrued its payouts for 63 consecutive years; this makes it portion of the elite nine of Dividend Kings. You tin number connected 2 hands the fig of companies with a much awesome streak than Coca-Cola successful this department.
However, the past can't archer america everything. Even if Coca-Cola has had an unthinkable dividend history, we inactive request to bash much enactment and look astatine the company's concern and prospects. Fortunately, investors person small to fear.